Marking its departure from the TAVR market, Boston Scientific officially discontinued sales of its Acurate neo2 and Acurate Prime TAVR systems and will no longer seek approval from the FDA or other regulatory agencies. cardiacwire.com/boston-scienti…

Diving deeper into the ABYSS trial, a new sub-analysis suggests that patients with MI and preserved LVEF who stop taking their beta-blockers experience significant rises in heart rate and BP, potentially increasing their risk of adverse events. cardiacwire.com/deeper-answers…

Regeneron announced it will pay Hansoh Pharma $80M upfront and up to $1.93B in milestone payments for its Phase 3-stage GLP-1/GIP drug, HS-20094. cardiacwire.com/regeneron-hans…

New ACC registry data suggests interventional cardiologists are using less contrast for PCI procedures in the cath lab which helps reduce post-PCI acute kidney injury risks, but a deeper look tells us there’s still room for improvement. cardiacwire.com/contrast-use-d…

Bringing a more effective BP therapy to the U.S. market, the FDA approved George Medicines’ triple therapy polypill called Widaplik for patients with hypertension, making it the first of its kind to go to market in the U.S. cardiacwire.com/fda-approves-a…

In the latest Cardiac Wire, we discuss… 🫀Abelacimab's periprocedural safety! 🫀Ablation during CABG! 🫀Lp(a)'s impact on PREVENT... And more #cardiology news. Check it out below. #CardioTwitter #MedTwitter cardiacwire.com/newsletter/abe…

In the latest Cardiac Wire, we discuss… 🫀Lilly Buys Verve 🫀Cold-Triggered AFib 🫀And a new GLUCOSE Algorithm And more #cardiology news. Check it out below. #CardioTwitter #MedTwitter cardiacwire.com/newsletter/lil…

Over a year after becoming the first FDA-approved transcatheter tricuspid valve replacement system, a new JACC study suggests Edwards Lifesciences’ Evoque TTVR system might have some risks that regulators hadn’t previously considered. cardiacwire.com/edwards-evoque…

In the latest Cardiac Wire, we discuss… 🫀Save the Planet to Save Our Hearts (From Microplastics) 🫀EnCompass’ First F2 Patient 🫀J&J Anti-Trust Plot Thickens And more #cardiology news. Check it out below. #CardioTwitter #MedTwitter cardiacwire.com/newsletter/mic…

A recent AHA study suggests there could be a link between ocean microplastic levels and cardiovascular disease in U.S. coastal counties, adding to a concerning trend of microplastics and CV risk. cardiacwire.com/save-the-plane…